Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 18, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 340,618 | -- | 340,618 |
| Feb 18, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 110,309 | -- | 418,526 |
| Feb 18, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 133,708 | -- | 133,708 |
| Feb 18, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 314,213 | -- | 314,213 |
| Feb 18, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 110,309 | -- | 354,807 |
| Feb 18, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 133,708 | -- | 113,708 |
| Feb 18, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 314,213 | -- | 314,213 |
| Feb 18, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 134,410 | -- | 464,668 |
| Feb 18, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 162,921 | -- | 162,921 |
| Feb 18, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 382,865 | -- | 382,865 |
| Feb 18, 2021 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 278,090 | -- | 648,119 |
| Feb 18, 2021 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 337,079 | -- | 337,079 |
| Feb 18, 2021 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 792,135 | -- | 792,135 |
| Feb 17, 2021 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | $3.61 | 125,967 |
| Feb 10, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 2,500 | $3.93 | 244,498 |
| Feb 10, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Other acquisition or disposition | -- | -- | 6,250 |
| Feb 09, 2021 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 1,977 | $3.93 | 246,998 |
| Jan 20, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 1,944 | $4.31 | 330,608 |
| Jan 20, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Form 4 | Other acquisition or disposition | -- | -- | 11,840 |
| Jan 20, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Open market or private sale of non-derivative or derivative security | 10,000 | $4.31 | 330,258 |
| Jan 20, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Other acquisition or disposition | -- | -- | 14,139 |
| Jan 20, 2021 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Open market or private sale of non-derivative or derivative security | 3,889 | $4.31 | 370,029 |
| Jan 20, 2021 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Other acquisition or disposition | -- | -- | 1,538 |
| Jan 19, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 2,582 | $3.81 | 332,552 |
| Jan 19, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Open market or private sale of non-derivative or derivative security | 64,626 | $4.00 | 351,915 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.